ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration. Hickey told Proactive this FDA approval represents a historic event for ReShape Lifesciences and is expected to serve as a pivotal driver of growth for the company's Lap-Band franchise. The development of the enhanced Lap-Band 2.0 FLEX was led by physicians with a primary focus on improving the overall patient experience. The Lap-Band 2.0 FLEX features innovative FLEX Technology, which acts as a relief valve.
This technology enables larger pieces of food to pass through the narrowed passage created by the band more comfortably. Specifically, the band briefly relaxes before returning to its resting diameter, reducing discomfort associated with the passage of large food items through the stoma. This FDA approval marks a significant milestone for ReShape Lifesciences, highlighting the company's commitment to advancing patient-centered innovations in the field of medical devices. The enhanced Lap-Band® 2.0 FLEX is poised to offer an improved and more comfortable solution for individuals seeking medical intervention for weight management and obesity-related concerns.